Informatics

Natural Language Processing in Oncology – Review
Tech & Innovation Natural Language Processing in Oncology – Review

Imagine a world where the vast, often chaotic troves of medical records can be instantly decoded to save lives, particularly for cancer patients facing complex diagnoses like brain metastases. In oncology, where every detail in a patient’s history can mean the difference between effective treatment

Cedars-Sinai Innovates Healthcare with AI and Big Data
Tech & Innovation Cedars-Sinai Innovates Healthcare with AI and Big Data

Imagine a hospital where doctors can predict medication side effects before they occur, or a global network of medical researchers sharing critical data without risking patient privacy. This scenario is no longer a distant dream but a tangible reality being shaped by leading institutions like

How Does HPC Revolutionize Atrial Fibrillation Research?
Tech & Innovation How Does HPC Revolutionize Atrial Fibrillation Research?

What if the erratic rhythm of millions of hearts could be decoded not by a stethoscope, but by the raw power of supercomputers? Atrial fibrillation (AF), the most common type of irregular heartbeat, silently threatens lives worldwide, often leading to devastating strokes. This condition,

Can Microbiome Science Revolutionize Everyday Patient Care?
Research & Development Can Microbiome Science Revolutionize Everyday Patient Care?

In an era where personalized medicine is increasingly becoming the norm, microbiome science is emerging as a pivotal player in reshaping patient care. Understanding the intricate relationship between human health and the billions of microbes that inhabit our bodies presents a unique opportunity. By

Boosting Pediatric Trials: KU and UNMC's $31M NIH Grant
Research & Development Boosting Pediatric Trials: KU and UNMC's $31M NIH Grant

The University of Kansas Medical Center (KU Medical Center) and the University of Nebraska Medical Center (UNMC) have embarked on an ambitious endeavor to revolutionize pediatric clinical research, with a significant boost from a $31 million grant awarded by the National Institutes of Health (NIH).

CHAF1B: A Key Oncogenic Driver in Lung Squamous Cell Carcinoma
Research & Development CHAF1B: A Key Oncogenic Driver in Lung Squamous Cell Carcinoma

Lung cancer remains one of the most lethal cancers worldwide, with survival rates hovering at a discouraging low despite advances in treatment. Among various types, lung squamous cell carcinoma (LUSC) poses unique challenges due to its aggressive nature and limited treatment options. The complexity

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later